Clinical Trials on Skin Infections (Acne)

Total 102715 results

Sebacia, Inc.

Unknown

Sebacia Postmarket Study of Real-World Use

Acne Vulgaris

United States
Akorn, Inc.

Completed

Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris

Acne Vulgaris

United States, Belize
Bausch Health Americas, Inc.

Completed

Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Naked Biome, Inc.
Dermatology Research Institute; Science 37; QST Consultations

Completed

A Study of the Safety, Engraftment, and Action of NB01 in Adults With Moderate Acne

Acne Vulgaris

United States
Naked Biome, Inc.
Therapeutics, Inc.

Completed

A Study of the Safety, Engraftment, and Action of Multi-Dosed NB01 in Adults With Moderate Acne

Acne Vulgaris

United States
Dermata Therapeutics

Completed

DMT310-001 Topical in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Dermata Therapeutics

Completed

DMT310-003 Topical in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Aurobindo Pharma Ltd

Withdrawn

Clinical Endpoint Bioequivalence Study of Adapalene Gel 0.1%

Acne Vulgaris
Sukma Skin Treatment

Completed

Decreasing Severity of Acne Vulgaris After the Use of a Combination of Anti-Acne Cream

Acne Vulgaris

Indonesia
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...

Completed

A Study on Safety and Preliminary Efficacy of ALA in Acne Vulgaris

Acne Vulgaris

China
Actavis Inc.

Completed

Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris

Acne Vulgaris

United States
Lee's Pharmaceutical Limited
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of Adapalene-Clindamycin Combination Gel in the Treatment of Acne Vulgaris

Acne Vulgaris

China
Torrent Pharmaceuticals Limited
Catawba Research

Completed

Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris

United States, Belize
Taro Pharmaceuticals USA

Completed

Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Indonesia University

Completed

Comedone Extraction and Oral Doxycycline In The First Line Treatment of Moderate Acne Vulgaris

Acne Vulgaris
Bausch Health Americas, Inc.

Completed

Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With Control Gel

Acne Vulgaris

United States
Bausch Health Americas, Inc.

Completed

A Study of a New Drug Treatment for Acne

Acne Vulgaris

United States
Novan, Inc.

Completed

A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers

Acne Vulgaris

United States
Assiut University

Unknown

Role of Vitamin D and Its Topical Analogues in Pathogenesis and Treatment of Acne Vulgaris

Acne Vulgaris
Almirall, S.A.
Allergan

Completed

Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne

Acne Vulgaris

United States
Almirall, S.A.
Allergan

Completed

Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne

Acne Vulgaris

United States
Almirall, S.A.
Allergan

Completed

A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Novan, Inc.

Completed

A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne

Acne Vulgaris

Dominican Republic, Honduras, Panama
Novan, Inc.
Spaulding Clinical Research LLC

Completed

A Thorough ECG Study in Subjects With Acne Vulgaris Treated With SB204

Acne Vulgaris

United States
Almirall, S.A.
Allergan

Completed

Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris

Acne Vulgaris

United States, Canada
Wake Forest University

Completed

Analysis of Adherence in Subjects Undergoing Differin Gel, 0.1% Treatment of Moderate to Severe Acne Vulgaris

Acne Vulgaris

United States
Fougera Pharmaceuticals Inc.

Completed

A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Merete Haedersdal
Sebacia, Inc.

Completed

Imaging of Pilosebaceous Units and Acne Lesions by RCM and OCT Confocal Microscopy and Optical Coherence Tomography

Acne Vulgaris

Denmark
Assiut University

Unknown

Apelin12 in Acne Vulgaris

Acne Vulgaris
University Hospital, Antwerp

Unknown

Studying the Skin Microbiome and the Potential of a Topical Probiotic Cream for Patients With Acne

Acne Vulgaris

Belgium
BioPharmX, Inc.

Completed

BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes

Acne Vulgaris

United States
Moe Medical Devices

Terminated

Safety Study of Plasma Treatment System to Treat Back Acne

Acne Vulgaris

United States
Sebacia, Inc.

Completed

Multiple Arm Study of Sebacia Microparticles in the Treatment of Acne Vulgaris

Acne Vulgaris

Poland
GlaxoSmithKline

Completed

Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris

Acne Vulgaris

Germany
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy Volunteers

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers

Acne Vulgaris

United States
Assiut University

Unknown

Polymorphism of Extrapituitary Promoter of PRL Gene and Relationships With Serum Prolactin Levels in Acne Vulgaris.

Acne Vulgaris
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris

Acne Vulgaris

Poland, United Kingdom
GlaxoSmithKline

Completed

Study to Investigate the Irritation Potential of GSK1940029 Gel

Acne Vulgaris

Australia
Taro Pharmaceuticals USA

Completed

A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris
Taro Pharmaceuticals USA

Completed

Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications

Acne Vulgaris

United States
Maruho Co., Ltd.

Completed

A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne

Acne Vulgaris

United States
GlaxoSmithKline

Completed

A Efficacy and Safety of Duac™Compared With Clindamycin Phosphate Gel in the Treatment of Mild to Moderate Acne Vulgaris

Acne Vulgaris

China
University of Michigan

Completed

Non-cutting Laser Therapy in the Treatment of Acne

Acne Vulgaris

United States
Maruho Co., Ltd.

Completed

Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris

Acne Vulgaris

United States
Valeant Pharmaceuticals

Unknown

A Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris

Acne Vulgaris
Valeant Pharmaceuticals

Unknown

A Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

Acne Vulgaris
Valeant Pharmaceuticals

Unknown

Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac Cream in the Treatment of Acne Vulgaris

Acne Vulgaris

3

Subscribe